Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non-small cell lung cancer

MLA

Chang-Min Choi, et al. “Efficacy of Natural Killer Cell Activity as a Biomarker for Predicting Immunotherapy Response in Non-Small Cell Lung Cancer.” Thoracic Cancer, vol. 11, no. 11, July 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dc4e544f7f2c7c60dcb62bd3b556f6f6&authtype=sso&custid=ns315887.

APA

Chang-Min Choi, Yeon Joo Kim, Jin Kyung Rho, Myeong Geun Choi, & Jae Cheol Lee. (2020). Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non-small cell lung cancer. Thoracic Cancer, 11(11).

Chicago

Chang-Min Choi, Yeon Joo Kim, Jin Kyung Rho, Myeong Geun Choi, and Jae Cheol Lee. 2020. “Efficacy of Natural Killer Cell Activity as a Biomarker for Predicting Immunotherapy Response in Non-Small Cell Lung Cancer.” Thoracic Cancer 11 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dc4e544f7f2c7c60dcb62bd3b556f6f6&authtype=sso&custid=ns315887.